Part @a of this pilot study was conducted at @ sites in the United States and Puerto Rico between September @ and August @ and included @ patients with HCV genotype @ and HIV-@ co-infection who were HCV treatment-naive or had history of prior treatment failure with peginterferon plus ribavirin therapy .